What Is NAD+ and What Have Studies Revealed About This Coenzyme?

Introduction: What Is NAD+?

Nicotinamide adenine dinucleotide, universally abbreviated NAD+, is a coenzyme found in every living cell. It exists in two interconvertible forms: the oxidized form (NAD+) and the reduced form (NADH). Together, these two states allow the molecule to shuttle electrons through metabolic pathways, making it indispensable for energy production, redox chemistry, and a growing list of signaling functions that researchers have only begun to map.

NAD+ research has expanded dramatically over the past two decades. Scientists studying aging, mitochondrial function, and cellular stress responses have identified NAD+ as a molecule that appears at the intersection of multiple fundamental biological processes. It is worth noting at the outset that the majority of mechanistic and interventional findings come from in vitro cell culture studies and animal models. Evidence in humans remains limited, and no compound discussed here should be interpreted as a treatment, therapy, or supplement with established clinical efficacy.

Core Biochemistry: How NAD+ Functions in Cells

At its most basic, NAD+ serves as an electron carrier. During glycolysis and the citric acid cycle, NAD+ accepts electrons and hydrogen ions to become NADH. NADH then donates those electrons to the mitochondrial electron transport chain, driving the synthesis of ATP, the primary energy currency used by cells. This oxidation-reduction cycle is continuous in metabolically active tissue.

Beyond energy metabolism, NAD+ also acts as a substrate, meaning it is directly consumed rather than simply shuttled, in at least three major enzymatic families:

• Sirtuins (SIRT1 through SIRT7): NAD+-dependent deacylases that remove acetyl groups from histones and other proteins, influencing gene expression, DNA repair, and mitochondrial biogenesis.
• PARPs (Poly-ADP-ribose polymerases): Enzymes that consume NAD+ to add ADP-ribose chains to proteins, a modification critical for DNA damage detection and repair.
• CD38 and CD157: Ectoenzymes that cleave NAD+ to produce second messengers such as cyclic ADP-ribose, which influence calcium signaling pathways.

Because these enzyme families collectively consume large amounts of NAD+, cellular NAD+ availability becomes a rate-limiting factor in multiple signaling pathways simultaneously, a property that makes NAD+ research particularly compelling to investigators studying aging and metabolic disease.

NAD+ is not merely a cofactor for redox reactions; it functions as a signaling hub whose intracellular concentration shapes the activity of entire regulatory networks within the cell.

NAD+ Levels and the Aging Question in Preclinical Research

One of the most consistently reported observations in NAD+ research is that tissue NAD+ concentrations decline with age in rodents and, according to a smaller number of studies, in human tissues as well. Researchers have proposed that this decline may contribute to age-associated phenotypes by impairing PARP-mediated DNA repair and reducing sirtuin activity.

In animal model studies, strategies aimed at restoring NAD+ levels, including genetic overexpression of NAD+ biosynthesis enzymes and administration of NAD+ precursors, have been associated with improvements in markers of metabolic function, muscle physiology, and cognitive performance. These findings are intriguing but firmly preclinical: they were observed in mice and rats under controlled laboratory conditions, and extrapolation to human aging biology requires caution.

For a broader look at how preclinical findings are interpreted in longevity research, see the companion article on mitochondrial peptides, which covers a related cluster of molecules being investigated for their roles in cellular energy maintenance.

NAD+ Biosynthesis: How Cells Make and Recycle This Coenzyme

Cells synthesize NAD+ through several interconnected pathways. Understanding these routes is important for interpreting NAD+ research, because many studies use precursor molecules that feed into one or more of them.

The Salvage Pathway

The predominant route in most mammalian tissues. Nicotinamide (Nam), released when NAD+ is consumed by sirtuins or PARPs, is recycled back to NAD+ via nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in this cycle. This pathway is sometimes called the NAD+ recycling or salvage pathway.

The Preiss-Handler Pathway

Converts nicotinic acid (niacin, vitamin B3) to NAD+ through a series of enzymatic steps. This route has been studied since the mid-twentieth century and underpins the nutritional significance of niacin in human biology.

De Novo Synthesis from Tryptophan

Tryptophan can be converted to NAD+ through the kynurenine pathway. This route is relatively minor under normal conditions but may become more relevant under inflammatory states, according to preclinical data.

NMN and NR as Research Precursors

Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are intermediates in the salvage pathway that have attracted significant research attention because they can be taken up by cells and converted to NAD+ more efficiently than nicotinamide alone in certain experimental contexts. For a detailed comparison of these two precursors from a research standpoint, see the article NMN vs NR: what the research shows.

Key Areas of Active NAD+ Research

NAD+ research spans multiple disease models and biological contexts. The table below summarizes the main research areas, the model systems employed, and the current state of evidence.

Researchers have also begun exploring the relationship between NAD+ metabolism and the immune system, particularly through the CD38 axis. In rodent aging models, CD38 activity increases with age and may contribute to NAD+ depletion by catabolizing the coenzyme at a high rate. This observation has made CD38 an emerging target of interest in NAD+ biology, though this line of investigation remains at an early mechanistic stage.

NAD+ and Sirtuin Signaling: A Central Research Axis

Among the signaling pathways linked to NAD+, the sirtuin family has received the most attention in longevity-focused research. Sirtuins require NAD+ as a cofactor for every catalytic cycle, which means their activity is directly sensitive to intracellular NAD+ concentrations. When NAD+ is abundant, sirtuin activity tends to be higher; when NAD+ is depleted, as occurs during DNA damage responses driven by PARP activation, sirtuin activity falls.

In animal models, SIRT1 and SIRT3 have been associated with regulation of mitochondrial biogenesis via PGC-1 alpha activation, a pathway also studied in the context of molecules like SS-31 (Elamipretide) and Humanin, two mitochondria-targeted peptides investigated for their effects on mitochondrial membrane potential and cellular stress responses. The convergence of these separate research threads on mitochondrial function illustrates why NAD+ occupies a central place in longevity biology discussions.

It is important to state clearly that sirtuin activation by NAD+ repletion in animal models has not been demonstrated to extend human lifespan or treat any human disease. These are mechanistic observations from controlled experimental systems.

Research Limitations and What the Evidence Does Not Show

Any honest appraisal of NAD+ research must acknowledge significant limitations:

• Most evidence is preclinical. The majority of mechanistic and functional findings come from cell culture or rodent experiments. These models do not reliably predict human outcomes.
• Bioavailability and tissue distribution are incompletely characterized. How efficiently administered NAD+ precursors raise NAD+ in specific human tissues remains an open research question.
• Long-term effects are unknown. Sustained elevation of NAD+ levels may have off-target effects on PARP activity, immune signaling, and other NAD+-consuming pathways that have not been fully characterized.
• Cause versus correlation in aging. Whether declining NAD+ is a primary driver of age-related phenotypes or a downstream consequence of other aging processes has not been definitively resolved.

Researchers and institutions studying NAD+ precursors or related compounds at the laboratory level should ensure that all materials are sourced with documented purity. EVO Labs Research publishes a Certificate of Analysis for all research compounds, reflecting HPLC-verified purity and identity testing.

NAD+ Research Compounds Available for Laboratory Use

EVO Labs Research supplies compounds relevant to NAD+ and longevity research pathways strictly for laboratory and in vitro research purposes. Investigators studying cellular metabolism and mitochondrial function may find the longevity research compounds catalog relevant, including molecules studied alongside NAD+ biology such as MOTS-c, Epithalon, and SS-31. These are research-grade materials intended for use in controlled laboratory settings only, not for human administration.

As with all research compounds, proper handling, storage, and documentation protocols should be followed. See the overview of peptide storage and stability for guidance applicable to lyophilized research materials.